{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:34:18Z","timestamp":1792805658985,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jmb.2025.169121","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T16:21:10Z","timestamp":1743610870000},"page":"169121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Distinct Allosteric Networks in CDK4 and CDK6 in the Cell Cycle and in Drug Resistance"],"prefix":"10.1016","volume":"437","author":[{"given":"Wengang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Bradburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Heidebrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunbum","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Nussinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardo","family":"K\u00f5ivom\u00e4gi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2025.169121_b0005","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/MCB.01823-08","article-title":"Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation","volume":"29","author":"Bockstaele","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0010","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1495","article-title":"CDK4 and CDK6 kinases: From basic science to cancer therapy","volume":"375","author":"Fassl","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jmb.2025.169121_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101103","article-title":"Mechanisms of sensitivity and resistance to CDK4\/CDK6 inhibitors in hormone receptor-positive breast cancer treatment","volume":"76","author":"Glaviano","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jmb.2025.169121_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1146047","article-title":"CDK6 is essential for mesenchymal stem cell proliferation and adipocyte differentiation","volume":"10","author":"Hu","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jmb.2025.169121_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28515-1","article-title":"Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma","volume":"13","author":"Ng","year":"2022","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2025.169121_b0030","series-title":"The cell cycle: principles of control","author":"Morgan","year":"2007"},{"key":"10.1016\/j.jmb.2025.169121_b0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41571-023-00840-4","article-title":"The CDK4\/6 inhibitor revolution \u2013 a game-changing era for breast cancer treatment","volume":"21","author":"Morrison","year":"2024","journal-title":"Nature Rev. Clin. Oncol."},{"key":"10.1016\/j.jmb.2025.169121_b0040","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0092-8674(00)81519-6","article-title":"Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1","volume":"98","author":"Harbour","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2025.169121_b0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.molcel.2013.04.003","article-title":"A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression","volume":"50","author":"Schachter","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2025.169121_b0050","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.molcel.2019.03.020","article-title":"Cyclin D-Cdk4,6 drives cell-cycle progression via the retinoblastoma protein's C-terminal helix","volume":"74","author":"Topacio","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2025.169121_b0055","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0092-8674(91)90557-F","article-title":"The E2F transcription factor is a cellular target for the RB protein","volume":"65","author":"Chellappan","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2025.169121_b0060","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1158\/1078-0432.CCR-15-1185","article-title":"FDA approval: palbociclib for the treatment of postmenopausal patients with estrogen receptor-positive, HER2-negative metastatic breast cancer","volume":"21","author":"Beaver","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jmb.2025.169121_b0065","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1158\/1078-0432.CCR-17-2369","article-title":"FDA approval: ribociclib for the treatment of postmenopausal women with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer","volume":"24","author":"Shah","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jmb.2025.169121_b0070","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ccell.2025.02.006","article-title":"CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety","volume":"43","author":"Palmer","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmb.2025.169121_b0075","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1073\/pnas.0709214104","article-title":"Allosteric cooperativity in protein kinase A","volume":"105","author":"Masterson","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169121_b0080","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jmb.2025.169121_b0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1158\/1078-0432.CCR-18-1999","article-title":"To cycle or fight\u2014CDK4\/6 inhibitors at the crossroads of anticancer immunity","volume":"25","author":"Ameratunga","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jmb.2025.169121_b0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.stem.2015.01.017","article-title":"CDK6 levels regulate quiescence exit in human hematopoietic stem cells","volume":"16","author":"Laurenti","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jmb.2025.169121_b0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/blood-2014-06-584417","article-title":"CDK6 as a key regulator of hematopoietic and leukemic stem cell activation","volume":"125","author":"Scheicher","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2025.169121_b0100","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1182\/blood-2014-02-555292","article-title":"Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis","volume":"124","author":"Rodriguez-Diez","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2025.169121_b0105","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2022.5184","article-title":"CDK4\/6 inhibitor resistance mechanisms and treatment strategies (Review)","volume":"50","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jmb.2025.169121_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13050987","article-title":"Mechanisms of resistance to CDK4\/6 inhibitors and predictive biomarkers of response in HR+\/HER2-metastatic breast cancer\u2014a review of the literature","volume":"13","author":"Stanciu","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.jmb.2025.169121_b0115","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1158\/2159-8290.CD-20-1726","article-title":"INK4 tumor suppressor proteins mediate resistance to CDK4\/6 kinase inhibitors","volume":"12","author":"Li","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jmb.2025.169121_b0120","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/onc.2016.379","article-title":"Acquired CDK6 amplification promotes breast cancer resistance to CDK4\/6 inhibitors and loss of ER signaling and dependence","volume":"36","author":"Yang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.jmb.2025.169121_b0125","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.celrep.2019.02.023","article-title":"MicroRNA-mediated suppression of the TGF-beta pathway confers transmissible and reversible CDK4\/6 inhibitor resistance","volume":"26","author":"Cornell","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2025.169121_b0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nsb0198-74","article-title":"Crystal structure of the CDK4\/6 inhibitory protein p18INK4c provides insights into ankyrin-like repeat structure\/function and tumor-derived p16INK4 mutations","volume":"5","author":"Venkataramani","year":"1998","journal-title":"Nature Struct. Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm9211","article-title":"Mitogen signaling strength and duration can control cell cycle decisions","volume":"10","author":"Nussinov","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jmb.2025.169121_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.774845","article-title":"Cyclin E\/CDK2: DNA replication, replication stress and genomic instability","volume":"9","author":"Fagundes","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0145","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.str.2024.04.012","article-title":"Slower CDK4 and faster CDK2 activation in the cell cycle","volume":"32","author":"Zhang","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2025.169121_b0150","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1021\/jacsau.4c00138","article-title":"CDK2 and CDK4: cell cycle functions evolve distinct, catalysis-competent conformations, offering drug targets","volume":"4","author":"Zhang","year":"2024","journal-title":"JACS Au."},{"key":"10.1016\/j.jmb.2025.169121_b0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/molpharm.121.000315","article-title":"The tails of protein kinase A","volume":"101","author":"Taylor","year":"2022","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jmb.2025.169121_b0160","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1073\/pnas.0610251104","article-title":"The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module","volume":"104","author":"Kannan","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169121_b0165","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/ncb1568","article-title":"Cdk1 coordinates cell-surface growth with the cell cycle","volume":"9","author":"McCusker","year":"2007","journal-title":"Nature Cell Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1126\/science.aba5186","article-title":"G1 cyclin-Cdk promotes cell cycle entry through localized phosphorylation of RNA polymerase II","volume":"374","author":"Koivomagi","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jmb.2025.169121_b0175","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.bpj.2022.05.030","article-title":"The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia","volume":"121","author":"Liu","year":"2022","journal-title":"Biophys. J."},{"key":"10.1016\/j.jmb.2025.169121_b0180","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/j.csbj.2022.08.014","article-title":"Allosteric regulation of autoinhibition and activation of c-Abl","volume":"20","author":"Liu","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jmb.2025.169121_b0185","doi-asserted-by":"crossref","first-page":"15609","DOI":"10.1039\/D1SC03444H","article-title":"The mechanism of Raf activation through dimerization","volume":"12","author":"Zhang","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jmb.2025.169121_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102438","article-title":"The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane","volume":"24","author":"Jang","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jmb.2025.169121_b0195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.csbj.2020.03.018","article-title":"The quaternary assembly of KRas4B with Raf-1 at the membrane","volume":"18","author":"Jang","year":"2020","journal-title":"Comput. Struct. Biotec."},{"key":"10.1016\/j.jmb.2025.169121_b0200","article-title":"Cell cycle progression mechanisms: slower cyclin-D\/CDK4 activation and faster cyclin-E\/CDK2","author":"Zhang","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jmb.2025.169121_b0205","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.str.2019.08.009","article-title":"The structural basis of the farnesylated and methylated KRas4B interaction with calmodulin","volume":"27","author":"Jang","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2025.169121_b0210","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmb.2025.169121_b0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nature Methods"},{"key":"10.1016\/j.jmb.2025.169121_b0220","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1021\/jp101759q","article-title":"Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types","volume":"114","author":"Klauda","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmb.2025.169121_b0225","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acs.jpcb.3c06662","article-title":"OpenMM 8: molecular dynamics simulation with machine learning potentials","volume":"128","author":"Eastman","year":"2023","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmb.2025.169121_b0230","article-title":"OpenMM 7: rapid development of high performance algorithms for molecular dynamics","volume":"13","author":"Gentleman","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0235","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: a toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmb.2025.169121_b0240","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.bpj.2015.08.015","article-title":"MDTraj: a modern open library for the analysis of molecular dynamics trajectories","volume":"109","author":"McGibbon","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.jmb.2025.169121_b0245","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/bioinformatics\/btl461","article-title":"Bio3d: an R package for the comparative analysis of protein structures","volume":"22","author":"Grant","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmb.2025.169121_b0250","series-title":"R: a language and environment for statistical computing","author":"Team","year":"2013"},{"key":"10.1016\/j.jmb.2025.169121_b0255","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmb.2025.169121_b0260","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/ct4008603","article-title":"Weighted implementation of suboptimal paths (WISP): an optimized algorithm and tool for dynamical network analysis","volume":"10","author":"Van Wart","year":"2014","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmb.2025.169121_b0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph Model."},{"key":"10.1016\/j.jmb.2025.169121_b0270","series-title":"The PyMOL molecular graphics system","author":"DeLano","year":"2002"},{"key":"10.1016\/j.jmb.2025.169121_b0275","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180112","article-title":"Structural insights into the functional diversity of the CDK-cyclin family","volume":"8","author":"Wood","year":"2018","journal-title":"Open Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102247","article-title":"Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors","volume":"298","author":"Arter","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2025.169121_b0285","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ccell.2016.02.010","article-title":"Activation mechanism of oncogenic deletion mutations in BRAF, EGFR, and HER2","volume":"29","author":"Foster","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmb.2025.169121_b0290","doi-asserted-by":"crossref","DOI":"10.1039\/D3CB00114H","article-title":"Protein conformational ensembles in function: roles and mechanisms","author":"Nussinov","year":"2023","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102722","article-title":"Cell phenotypes can be predicted from propensities of protein conformations","volume":"83","author":"Nussinov","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0300","doi-asserted-by":"crossref","first-page":"29227","DOI":"10.1039\/D1RA03820F","article-title":"CDK4\/6 inhibitors: a brief overview and prospective research directions","volume":"11","author":"Adon","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmb.2025.169121_b0305","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw2106","article-title":"p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition","volume":"366","author":"Guiley","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jmb.2025.169121_b0310","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature05959","article-title":"Conformational entropy in molecular recognition by proteins","volume":"448","author":"Frederick","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2025.169121_b0315","doi-asserted-by":"crossref","first-page":"15052","DOI":"10.1073\/pnas.1900163116","article-title":"Dynamic allostery-based molecular workings of kinase:peptide complexes","volume":"116","author":"Ahuja","year":"2019","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169121_b0320","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tibs.2015.09.002","article-title":"Dynamics-driven allostery in protein kinases","volume":"40","author":"Kornev","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jmb.2025.169121_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100746","article-title":"From structure to the dynamic regulation of a molecular switch: a journey over 3 decades","volume":"296","author":"Taylor","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2025.169121_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002179","article-title":"Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases","volume":"7","author":"Dixit","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2000127","article-title":"Decoding the interactions regulating the active state mechanics of eukaryotic protein kinases","volume":"14","author":"Meharena","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0340","doi-asserted-by":"crossref","first-page":"ND12","DOI":"10.1158\/1538-7445.AM2024-ND12","article-title":"Abstract ND12: discovery of PF-07220060, a potent and selective CDK4 inhibitor","volume":"84","author":"Anders","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.jmb.2025.169121_b0345","doi-asserted-by":"crossref","first-page":"E4623","DOI":"10.1073\/pnas.1418402111","article-title":"Dynamic architecture of a protein kinase","volume":"111","author":"McClendon","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169121_b0350","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.chembiol.2005.04.011","article-title":"Features of selective kinase inhibitors","volume":"12","author":"Knight","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jmb.2025.169121_b0355","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2317756121","article-title":"Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2","volume":"121","author":"Schonherr","year":"2024","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169121_b0360","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12964-019-0450-3","article-title":"Distinct functions of AKT isoforms in breast cancer: a comprehensive review","volume":"17","author":"Hinz","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jmb.2025.169121_b0365","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cell.2018.07.003","article-title":"Akt kinase activation mechanisms revealed using protein semisynthesis","volume":"174","author":"Chu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2025.169121_b0370","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1021\/acsmedchemlett.3c00356","article-title":"Targeted degradation of CDK4\/6: an innovative approach to overcoming cancer drug resistance","volume":"14","author":"Kargbo","year":"2023","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283625001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283625001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:09:33Z","timestamp":1778645373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283625001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":74,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022283625001871"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2025.169121","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.02.28.640857","asserted-by":"object"}]},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct Allosteric Networks in CDK4 and CDK6 in the Cell Cycle and in Drug Resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2025.169121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"169121"}}